Insurance Denied Rehab or Addiction Treatment? How to Appeal in 2026

If you were just denied, start here

Take a breath. A denial letter feels like a door slamming, especially when someone’s recovery or safety is on the line, but it is often the opening move in a process that you can push back on, not the final word. Insurers deny and shorten addiction-treatment claims routinely, and a large share of those decisions are overturned when patients and providers appeal with good clinical documentation. You have real rights here.

Two things matter most in the first 48 hours. First, keep the treatment going if it is clinically needed and you can, because a gap in care is dangerous and because leaving against medical advice can weaken an appeal. Talk to the facility’s billing and clinical staff about staying while you dispute the decision. Second, start a paper trail: save the denial letter, write down the date, and open a simple log where you record every phone call (date, the name of the person you spoke with, and what was said). You will lean on that log throughout the appeal.

If you or a loved one is in immediate crisis, do not wait on an appeal. Call or text 988 (the Suicide and Crisis Lifeline, which also handles substance use crises), or call SAMHSA’s free, confidential National Helpline at 1-800-662-HELP (4357), available 24 hours a day, 7 days a week, for referrals including low-cost and free options.

• Get the denial in writing and note the exact reason given.
• Ask the insurer which specific medical-necessity criteria or ASAM level it applied, and request those in writing.
• Ask your treatment provider to begin a medical-necessity letter right away.
• Start a call log and keep every letter, bill, and Explanation of Benefits.
• Note your appeal deadline (often 180 days) and whether your situation qualifies for an expedited (urgent) appeal.

Your rights: parity protects addiction treatment

The Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA) is the single most important law behind an addiction-treatment appeal. It protects substance use disorder (SUD) treatment as a covered condition, right alongside mental health. If a plan covers addiction benefits at all (most large-group plans, ACA Marketplace plans, and Medicaid managed care must), it cannot apply stricter rules to that care than it applies to comparable medical and surgical care.

Parity works on two levels. The first is quantitative limits: copays, coinsurance, deductibles, and visit or day limits. A plan cannot charge you more for a rehab day than for a comparable inpatient medical day, and it cannot cap addiction treatment at a set number of days if it does not cap comparable medical stays. The second level is often more important: non-quantitative treatment limitations (NQTLs). These are the harder-to-see rules, like prior authorization, concurrent review (day-by-day re-checks), step therapy (fail first), the medical-necessity standard used, and how narrow the provider network is. Parity means a plan cannot review, pre-authorize, or second-guess addiction care more aggressively than it does medical care. If your plan demands prior authorization and repeated concurrent reviews for residential addiction treatment but does not require the same for a comparable medical admission, that is a parity red flag worth raising in your appeal.

A status note for 2026, because this area is genuinely in flux. The 2024 MHPAEA final rule tightened NQTL requirements and required plans to produce a written comparative analysis showing their addiction limits are truly comparable to medical limits. In May 2025 the federal Departments (Labor, Health and Human Services, and Treasury) announced they would not enforce the portions of that 2024 rule that were new, pending litigation plus an additional 18 months. That does not repeal parity. The underlying MHPAEA statute and the 2013 regulations remain fully in effect, and the Consolidated Appropriations Act, 2021 requirement that a plan hand over its NQTL comparative analysis on request also remains in force. You or your provider can request that analysis in writing, and many states enforce their own parity laws for state-regulated plans.

How insurers judge medical necessity: the ASAM Criteria

Most insurers decide whether addiction treatment is medically necessary, and which level of care is appropriate, using The ASAM Criteria from the American Society of Addiction Medicine. The 4th Edition for adults was released in 2023 and is being adopted by payers (for example, Optum and UnitedHealth began phasing in the 4th Edition for adult SUD in late 2023). Understanding this framework is how you turn a denial into a documented, winnable appeal, because you can speak the insurer’s own language.

Placement is decided by an ASAM Level of Care Assessment scored across six dimensions: (1) intoxication and withdrawal risk, (2) biomedical conditions and complications, (3) emotional, behavioral, and cognitive conditions, (4) readiness to change, (5) relapse and continued-use potential, and (6) recovery environment. Insurers use these dimensions to judge medical necessity and the right level of care, so having your provider document all six is central to both approvals and appeals. A letter that walks through each dimension is far harder to deny than a general statement that treatment is needed.

The levels run from least to most intensive. The exact sublevel labels shifted somewhat in the 4th Edition, so confirm the specific label with your provider or plan, but the broad continuum is consistent.

• Level 1: Outpatient services. Regularly scheduled sessions, generally under 9 hours per week for adults, while you live at home.
• Level 2.1: Intensive Outpatient (IOP). Usually 9 or more hours of structured programming per week while living at home.
• Level 2.5: Partial Hospitalization (PHP), sometimes called day treatment. Usually 20 or more hours per week, more intensive than IOP, but you still go home at night.
• Level 3: Residential and inpatient care in a 24-hour setting, with sublevels of increasing intensity (commonly described as roughly 3.1 for low-intensity residential up through 3.5 and 3.7 for higher-intensity, co-occurring-capable, and medically managed residential).
• Level 4: Medically managed intensive inpatient, with 24-hour nursing and physician care, used for acute medical withdrawal and serious medical or psychiatric instability. In the 4th Edition, withdrawal management (detox) was folded into this main continuum rather than sitting on a separate track.

The Wit v. UBH context: criteria should reflect real standards of care

There is a well-known legal backdrop worth understanding, because the principle behind it is something you can invoke in an appeal. In the long-running class action Wit v. United Behavioral Health, a court found that UBH had used internal medical-necessity criteria that were more restrictive than generally accepted standards of care and skewed toward cost savings, which the court held breached its ERISA fiduciary duty.

Be careful how you rely on it. The Ninth Circuit’s later 2023 rulings narrowed the remedies (for example, on whether plans must reprocess claims and on how specific plan language interacts with generally accepted standards), and the case saw multiple reversals and remands, so Wit is not a guaranteed win and you should confirm its current posture. Its lasting, practical value is the underlying idea: a plan’s medical-necessity criteria should reflect generally accepted standards of care, such as the ASAM Criteria, and not just cost control. If a denial seems to rest on criteria that are stricter than mainstream clinical standards, it is fair and reasonable to say so in your appeal and to ask the insurer to identify the criteria it used and how they compare to accepted standards.

Common denial reasons and how to counter each

Denials tend to fall into a handful of recognizable buckets. Knowing which one you are facing tells you exactly what to gather. In almost every case, the antidote is specific clinical documentation from your provider tied to the ASAM dimensions, plus a parity argument where the review looks more aggressive than it would be for medical care.

• Not medically necessary (the most common denial). Counter it with the provider’s ASAM Level of Care Assessment documenting all six dimensions and why this level is clinically indicated, plus records of prior treatment, relapse history, withdrawal risk, and any co-occurring conditions. Ask which specific medical-necessity criteria the insurer applied, and request them in writing.
• Wrong level of care (the insurer says a lower level, often outpatient, is enough). Counter with clinical detail showing why outpatient or IOP is unsafe or has already failed, using the six ASAM dimensions (for example, withdrawal risk, an unstable recovery environment, or serious co-occurring mental health needs).
• Length-of-stay cutoff or concurrent-review denial (approves a few days, then cuts you off). Counter by having the provider submit updated progress notes justifying continued stay, and by flagging parity if medical admissions are not subjected to the same aggressive day-by-day review.
• Failed or missing prior authorization. Counter by asking for a retroactive or expedited authorization, and note that emergency and acute withdrawal situations may not permit advance authorization. Keep the dates and names of everyone you spoke with.
• Out-of-network. Counter by requesting a network-adequacy or single-case exception if no in-network provider can deliver the needed level of care within a reasonable time or distance, and check whether state law or your plan requires in-network cost-sharing when the network is inadequate.

The appeal process, step by step

Here is a practical, ordered path. You will not always need every step, and some cases resolve at the peer-to-peer stage. Move quickly, because deadlines are real, but keep everything in writing and keep copies.

• 1. Get the denial in writing and identify the exact reason and the specific clinical criteria the insurer used (for example, which ASAM level or which internal medical-necessity guideline). You have a right to this and to your claim file.
• 2. Ask the treatment provider for a medical-necessity letter grounded in the ASAM Criteria, documenting all six ASAM dimensions and why the requested level of care is appropriate and safe.
• 3. Request a peer-to-peer review so your treating clinician can speak directly with the insurer’s reviewing physician, before or during the appeal.
• 4. File the internal appeal in writing within the plan’s deadline (often 180 days), attaching the medical-necessity letter, records, and any parity argument. Request an expedited internal appeal if a delay could jeopardize health.
• 5. If the internal appeal is denied, file for external review by an independent review organization. For many plans this decision is binding on the insurer. Ask your plan or state insurance department how to start it, and note that expedited external review exists for urgent cases.
• 6. Escalate to your state Department of Insurance (for state-regulated plans) or, for an employer self-funded ERISA plan, to the U.S. Department of Labor’s Employee Benefits Security Administration.
• 7. Consider filing a parity complaint (MHPAEA) with the same regulator if the addiction care was reviewed or limited more strictly than comparable medical care, and request the plan’s NQTL comparative analysis. Keep copies and a log of every call, name, and date throughout.

Out-of-network rehab and the No Surprises Act

Many addiction-treatment facilities operate wholly or partly outside insurance networks, which is one reason rehab bills get so large. The federal No Surprises Act (effective 2022) helps with some of these bills, but not all, so it is worth knowing exactly where it reaches.

It protects you in two main situations: emergency services (including emergency care for a behavioral health or SUD crisis, and in many cases acute detox or withdrawal treated as an emergency), and non-emergency care delivered by an out-of-network provider at an in-network facility (for example, an out-of-network clinician who treats you inside an in-network hospital). In those situations you generally owe only your in-network cost-sharing and are protected from balance billing (being billed for the gap between the provider’s charge and what the plan pays).

What it generally does not cover is a standalone, out-of-network residential rehab or detox facility that you chose and entered on a non-emergency basis. Those out-of-network stays are usually not shielded by the Act, and they are a frequent source of large surprise bills, so confirm the network status of both the facility and each individual clinician before admission when you can. If you were treated out-of-network, it is reasonable to ask the facility whether it will accept the insurer’s allowed amount, request an itemized bill, and appeal the out-of-network determination, especially if there was no adequate in-network option (a possible parity and network-adequacy argument). If you are uninsured or paying cash, you are entitled to a Good Faith Estimate before scheduled care, and you can use the patient-provider dispute resolution process if the final bill is at least 400 dollars above that estimate.

If you are uninsured, on Medicaid, or out of options

An appeal is not your only path to care. Medicaid is one of the largest payers for substance use treatment in the country. Under the ACA, SUD services are an essential health benefit for Medicaid expansion enrollees and Marketplace plans, and MHPAEA parity protections extend to Medicaid managed care and CHIP. Covered services commonly include screening, outpatient counseling, IOP and PHP, medication for addiction treatment (such as buprenorphine, methadone, and naltrexone), and, in many states, residential treatment (often through Section 1115 SUD demonstration waivers). Exact benefits and prior-authorization rules vary by state, so check your state Medicaid agency.

If you are uninsured or underinsured, treatment is still reachable. Call SAMHSA’s free, confidential National Helpline at 1-800-662-HELP (4357), available 24/7, or search FindTreatment.gov for licensed programs, including ones offering sliding-scale or free care. States also receive federal Substance Use Prevention, Treatment, and Recovery Services Block Grant funds through SAMHSA (in February 2026, SAMHSA distributed roughly 794 million dollars in combined mental health and substance use block grant funding, of which the substance-use portion was about 475 million dollars) that act as a safety net for low-income and uninsured people. Your state’s single agency for substance abuse can point you to block-grant-funded providers. Many facilities also offer charity care or payment plans, so ask.

Medication for addiction treatment (MAT), also called medications for opioid use disorder, is considered first-line, evidence-based care by SAMHSA and NIDA, and it is generally far cheaper than residential care. Buprenorphine can now be prescribed in a regular office setting since the X-waiver was eliminated by the Consolidated Appropriations Act, 2023. For oral options, generic oral naltrexone (formerly branded ReVia) is inexpensive, often about 30 to 150 dollars per month self-pay, and with insurance or Medicaid most people pay a modest copay or nothing for MAT, since it is an essential health benefit.

Won your appeal? Now check the bill

Getting treatment approved is a win, and it is also the moment to look closely at what you are billed. Rehab bills are complicated, and honest errors are common. Framing this the right way matters: this is about checking and correcting billing mistakes, not accusing anyone of wrongdoing. Request a fully itemized bill (not a summary) and match it against your Explanation of Benefits and a simple timeline of the days you were actually in treatment.

One area worth a careful look is urine drug testing (UDT). It is a routine and legitimate part of addiction treatment, but it is also one of the largest single sources of surprise charges on a rehab bill. Reasonable questions to ask, framed as questions and not accusations: How many separate testing dates were billed, and does that match the days you were actually in treatment? Were you billed for expensive definitive lab testing when only a quick on-site screen was done? Was testing billed as one tiered code per day, or broken out per substance in a way that multiplies the charge? Other things to check include being billed for a higher, costlier level of care than you actually received, charges for days you were not present, and unbundled per-diem items (the daily residential rate is supposed to include room, board, nursing, and routine therapy). For anything that looks off, ask the facility’s billing office for a corrected statement, and remember you generally have at least 180 days to appeal a plan’s payment decision.

If reviewing an itemized rehab bill, appealing a denial, or untangling an out-of-network toxicology bill feels like more than you want to take on while focusing on recovery, that is exactly what CareRoute Bill Defense exists for. We help patients and families check addiction-treatment bills line by line, dispute charges that cannot be verified, and push appeals through the process. For companion reading, see our guides on the cost of rehab, rehab bill red flags to watch for, and how to lower a mental-health bill at /costs/mental-health-bill-how-to-lower.

Frequently asked questions

Related resources